An insulin resistant state is evident in the brain early in AD progression [5, 6], and a number of epidemiological studies have identified Type-2 diabetes (T2D), in which an insulin resistant state exists, as a risk factor for developing AD [7–9]. Here, INS is linked to Alzheimer disease.